116 related articles for article (PubMed ID: 1679015)
1. Up-regulation of dopamine D2 receptor mRNA in rat striatum by chronic neuroleptic treatment.
Rogue P; Hanauer A; Zwiller J; Malviya AN; Vincendon G
Eur J Pharmacol; 1991 Jun; 207(2):165-8. PubMed ID: 1679015
[TBL] [Abstract][Full Text] [Related]
2. Decrease in mRNA levels but not in the density of D2 dopamine receptors in rat striatum after transient forebrain ischemia.
Benfenati F; Cimino M; Zoli M; Grimaldi R; Zini I; Agnati LF
Neurosci Lett; 1991 May; 126(1):6-8. PubMed ID: 1830941
[TBL] [Abstract][Full Text] [Related]
3. The effect of haloperidol on D2 dopamine receptor subtype mRNA levels in the brain.
Fishburn CS; David C; Carmon S; Fuchs S
FEBS Lett; 1994 Feb; 339(1-2):63-6. PubMed ID: 8313980
[TBL] [Abstract][Full Text] [Related]
4. Ontogenetic expression of D2 dopamine receptor mRNA in rat corpus striatum.
Chen JF; Weiss B
Brain Res Dev Brain Res; 1991 Nov; 63(1-2):95-104. PubMed ID: 1665109
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2-receptor mRNA level in rat striatum after chronic haloperidol treatment.
Matsunaga T; Ohara K; Natsukari N; Fujita M
Neurosci Res; 1991 Nov; 12(3):440-5. PubMed ID: 1664925
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneous distribution of dopamine D2 receptor mRNA in the rat striatum: a quantitative analysis with in situ hybridization histochemistry.
Szele FG; Artymyshyn R; Molinoff PB; Chesselet MF
Anat Rec; 1991 Dec; 231(4):548-58. PubMed ID: 1838906
[TBL] [Abstract][Full Text] [Related]
7. Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.
Srivastava LK; Morency MA; Bajwa SB; Mishra RK
J Mol Neurosci; 1990; 2(3):155-61. PubMed ID: 1703431
[TBL] [Abstract][Full Text] [Related]
8. Relationship between dopamine receptor occupation by spiperone and acetylcholine levels in the rat striatum after long-term haloperidol treatment depends on dopamine innervation.
Korf J; Sebens JB
J Neurochem; 1987 Feb; 48(2):516-21. PubMed ID: 2878979
[TBL] [Abstract][Full Text] [Related]
9. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors.
Prosser ES; Csernansky JG; Hollister LE
Life Sci; 1988; 43(8):715-20. PubMed ID: 2901023
[TBL] [Abstract][Full Text] [Related]
10. Aripiprazole, a novel antipsychotic drug, inhibits quinpirole-evoked GTPase activity but does not up-regulate dopamine D2 receptor following repeated treatment in the rat striatum.
Inoue A; Miki S; Seto M; Kikuchi T; Morita S; Ueda H; Misu Y; Nakata Y
Eur J Pharmacol; 1997 Feb; 321(1):105-11. PubMed ID: 9083792
[TBL] [Abstract][Full Text] [Related]
11. Dopamine receptor subtypes: differential regulation after 8 months treatment with antipsychotic drugs.
Florijn WJ; Tarazi FI; Creese I
J Pharmacol Exp Ther; 1997 Feb; 280(2):561-9. PubMed ID: 9023264
[TBL] [Abstract][Full Text] [Related]
12. Regulation of D1A and D2 dopamine receptor mRNA during ontogenesis, lesion and chronic antagonist treatment.
Xu SX; Monsma FJ; Sibley DR; Creese I
Life Sci; 1992; 50(5):383-96. PubMed ID: 1732708
[TBL] [Abstract][Full Text] [Related]
13. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
14. Lack of effect of chronic dopamine receptor blockade on D2 dopamine receptor mRNA level.
van Tol HH; Riva M; Civelli O; Creese I
Neurosci Lett; 1990 Apr; 111(3):303-8. PubMed ID: 1970862
[TBL] [Abstract][Full Text] [Related]
15. Changes in dopamine D1, D2 and D3 receptor mRNA levels in rat brain following antipsychotic treatment.
Buckland PR; O'Donovan MC; McGuffin P
Psychopharmacology (Berl); 1992; 106(4):479-83. PubMed ID: 1349752
[TBL] [Abstract][Full Text] [Related]
16. Chronic haloperidol affects striatal D2-dopamine receptor reappearance after irreversible receptor blockade.
Pich EM; Benfenati F; Farabegoli C; Fuxe K; Meller E; Aronsson M; Goldstein M; Agnati LF
Brain Res; 1987 Dec; 435(1-2):147-52. PubMed ID: 2962698
[TBL] [Abstract][Full Text] [Related]
17. Chronic neuroleptic treatment increases D-2 but not D-1 receptors in rat striatum.
MacKenzie RG; Zigmond MJ
Eur J Pharmacol; 1985 Jul; 113(2):159-65. PubMed ID: 2864265
[TBL] [Abstract][Full Text] [Related]
18. Differential modulation of dopamine D2 receptors by chronic haloperidol, nitrendipine, and pimozide.
Tecott LH; Kwong LL; Uhr S; Peroutka SJ
Biol Psychiatry; 1986 Oct; 21(12):1114-22. PubMed ID: 2428411
[TBL] [Abstract][Full Text] [Related]
19. Investigation of striatal dopamine D2 receptor acquisition following prenatal neuroleptic exposure.
Schmidt MH; Lee T
Psychiatry Res; 1991 Mar; 36(3):319-28. PubMed ID: 1676523
[TBL] [Abstract][Full Text] [Related]
20. Hypophysectomy does not prevent development of striatal dopamine receptor supersensitivity induced by repeated neuroleptic treatment.
Jenner P; Rupniak NM; Hall MD; Dyer R; Leigh N; Marsden CD
Eur J Pharmacol; 1981 Nov; 76(1):31-6. PubMed ID: 6119220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
